Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Stephen England discusses balancing elite ultramarathon competitions with a full-time job and diabetes
What is the role of the health humanities in diabetes care?
Tripling my carbs --> 5 fewer hours in-range per day, 64% more insulin (!), & more lessons learned.
Use 4 mm needles, rotate injection sites, and more – why the little stuff matters
New OneTouch Reveal app works with Apple and Android phones. Plus, a future partnership to integrate WellDoc’s FDA-approved BlueStar software.
Adam Brown leads expert panel discussion at The diaTribe Foundation’s first-ever digital health gathering at ADA 2016.
Who is “closing the loop,” and how fast are they moving?
MannKind has re-launched the inhaled mealtime insulin, Afrezza, alongside new initiatives to promote the product
80 days, 5 lbs of weight loss, and my strongest blood glucose numbers ever?
New Livongo Family Care Plan available without a prescription or insurance
Dr. Shreela Sharma’s advice for eating well, moving more, and making goals stick in the New Year
“Adam, what do you eat when you’re on a plane?” My six go-to strategies from hundreds of flights and airports
Full results of DEVOTE study presented at ADA 2017 show that basal insulin Tresiba reduces risk of severe hypoglycemia by 40% (by 53% overnight), in addition to being...
Recall applies to sets manufactured before April 2017; Medtronic is replacing old sets that have a risk of insulin over-delivery
Ginger Vieira and Jennifer Smith’s month-to-month guide for managing blood sugars, nutrition, exercise, and mental health during pregnancy
Lilly’s Humalog Junior KwikPen offers 0.5 unit dose increments in prefilled, disposable device – a win for highly insulin sensitive users
Express Scripts recently announced the launch of Inside Rx, a discount prescription program with savings ranging from 16% to nearly 80% for insulin and other diabetes...
Q&A with Bike Beyond riders on what got them through a 10-week cross country bike trip
CGMs with an insulin-dosing claim, like Dexcom’s G5, finally have a path to Medicare reimbursement; possible coverage in 2018 or earlier
Winning ideas aim to improve insulin safety, monitor for foot ulcers, and incorporate user insight into product development